Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
FOMO kicking in!
0.19s printing!!! We have a gem in the making here!
TAWNF GO!!!
I'm loading up huge right now. Calm before the news!
Sorry my last post was for another ticker, my bad. Still, this has 100 bagger potential written all over it. The rest of the world is still really struggling with COVID-19
$TAWNF Green days ahead!
$TAWNF smacks. Prepare for takeoff
Agreed and revenue will mean they won't need further capital raises in the future. Can't wait for REBORN1 trial results!
Well, whether it really treats cancer remains to be proven. That 2013 ABC report makes it a long shot at best. Hope so for you GL.
Pain relief is HUGE business BTW!
I'm in big in another ticker with only 53M share float!! and merged with $3B in Carbon offsets company, and ZERO dilution during merger process (so no CFGN MM type games).
Played the bounce and got out with minimum loss. Hope it works out for all but this is a scary stock.
Loading up!!!!
$TBPMF a 100X plus multi-bagger? This gentlemen made an excellent bullish case on YouTube why it might be a unicorn stock with very thorough DD.
See Link:
Great news! Health Canada Accepts New Drug Submission for REDUVO(TM) as a Treatment for Patients with Chemotherapy-induced Nausea and Vomiting
Wednesday, June 2, 2021 7:30 AM
Share this article now
Topic: Company Update
This news release constitutes a "designated news release" for the purposes of the Company's prospectus supplement dated May 28, 2021 to its short form base shelf prospectus dated April 1, 2020
The Company approaches a significant milestone advancing from a pre-revenue biotech to in revenue
OTTAWA, ON / ACCESSWIRE / June 2, 2021 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1), a leader in cannabinoid-derived drug discovery and development announced today that Health Canada has accepted its New Drug Submission (NDS) for REDUVOâ„¢ and has formally entered the final review phase in the drug review process. If successful, REDUVOâ„¢ will be issued a Notice of Compliance (NOC) as well as a Drug Identification Number (DIN) which permits Tetra to market the drug in Canada and indicates the drug's official approval in Canada.
REDUVOâ„¢ is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV). It is also used to treat weight loss and severe nausea in people living with HIV infection. The active pharmaceutical ingredient in REDUVOâ„¢ is dronabinol, also known as THC, a synthetic form of the active natural substance in cannabis.
"There is a need for alternative therapies for patients experiencing CINV who don't respond well to the conventional drugs used to control nausea and vomiting. Prevention of CINV remains a priority to reduce further illness in patients receiving chemotherapy. Tetra anticipates that REDUVOâ„¢ will be publicly and privately reimbursed by provinces and Canadian private healthcare plans," said Chief Executive Officer Dr. Guy Chamberland. "We will continue to work closely with Health Canada as we seek to bring this therapy to patients as soon as possible."
About Chemotherapy-induced Nausea and Vomiting
Chemotherapy-induced nausea and vomiting is one of the most common side effects of chemotherapy treatment. Some studies indicate that untreated CINV can affect up to 70% to 80% of all people undergoing chemotherapy1. Patients who poorly manage CINV may have a decreased quality of life.
About Tetra Bio-Pharma
Tetra Bio-Pharma (TSX:TBP) (OTCQB:TBPMF) (FRA:JAM1) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. Our evidence-based scientific approach has enabled us to develop a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing biopharma industry by regulators, physicians and insurance companies.
For more information visit: www.tetrabiopharma.com
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Exchange) accepts responsibility for the adequacy or accuracy of this release.
References:
Chemotherapy-Induced Nausea and Vomiting-Adult. Source: https://www.ons.org/pep/chemotherapy-induced-nausea-and-vomitingadult?display=pepnavigator&sort_by=created&items_per_page=50
Forward-Looking Statements
Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan" or "project" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company's ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company to obtain sufficient financing to execute the Company's business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company's research and development strategies, including the success of this product or any other product, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company's public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.
For further information, please contact Tetra Bio-Pharma Inc.:
Tetra Bio-Pharma Inc.
Ms. Natalie Leroux
Phone: + 1 (833) 977-7575
Email: investors@tetrabiopharma.com
media@tetrabiopharma.com
SOURCE: Tetra Bio-Pharma
Tetra Bio-Pharma
Tetra Bio-Pharma
Facebook Linked In Twitter
Back to Newsroom
Drop us a line: 888.952.4446
Email: Sales
Editorial
Content licensing
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy | Terms and Conditions
It's best for All (shareholders and Entrex etc) for any deal execution to happen after audited YE/Q1/Attorney Letter is submitted. This will be the final step for SEC to recognize merger between Entrex and UNSS and get CE removed, which in turn will allow to move forward on all fronts (Watkins will take over the lead as CEO and be in full control of future fins, Entrex revenue/ deals will be recognized in UNSS Fins although this might already be the case, etc.). Along with CE removal, it will be smooth sailing.
I'm not concerned about PPS. No one is selling and it will turn around very quickly once Fins are out. The wait for Fins has been frustrating for everyone including Watkins, but it will very much worth it. Hang in there.
UNSS Long & Strong
Just played one my first soccer games in over twenty years. I need this Lol
$BPSR a 100X plus multi-bagger? This gentlemen makes an excellent bullish case on YouTube why it might be a unicorn stock with very thorough DD.
See Link:
Amazing post. Well done!
Except that it's up 300% from Tuesday's close Lol
Also, a CEO comment I really liked:
"I feel very confident we are going to win against morphine"
TBPMF - HUGE POTENTIAL!
From the CEOs mouth to our ears:
Question: "How soon might you provide some insight as to how the head to head trial is going"
CEO: "We are hoping to give an update at the general assembly...that's on May 28th" *and they did, as you stated*
Here's the link, at 1:02:00 of the Youtube CEO interview May 11th when we wrote our post:
Agreed. We hold something special here. Onwards and upwards!
Peaked at almost 60 cents previously, should go much higher on that news!
$BPSR June is going to be crazy huge!
Back in and will keep long Lol. CFGN backed off and too many good things going on ;)
Cheers
Don't get me wrong, this has huge up potential long term. great DD by everyone here and I wasn't bashing. Just stated facts Re: call and CFGN holding this back. I'm still hoping to get back in at similar price but have better opportunities short term. Then I can use my profits to get back here before it really takes off. GL
Nah I sold on the Ask, no dump. I'm just a drop in the bucket, CFGN is the one you should worry about.
I'm out. CFGN is an ongoing concern short term. Will keep monitoring and might get back in depending on the action.
GLTA
Crap Lol
This is the email they gave me during the call!!! Lol
And yes, he's the CEO of CMW Media...never said QNTA but that does need clarifying ;)
My point is, this is the contact they gave me.
To be fair, they said during to contact them and they would respond to individual inquiries Re: convertible notes. So far, they haven't. The business side and the call are great, but this is my one negative regarding this stock in the short term.
"CEO NEVER said to email HIM ???????
EMAIL THEIR IR "INVESTOR RELATIONS" was his specific instructions on the conference call :"
Yes they did. I asked the question during the call and they responded with:
"I believe this is in the filings - please reach out to kyle@cmwmedia.com and we will ensure the public disclourse of this" which is the CEOs email.
Here's his response to the email I sent him Re: convertible notes:
"Kyle Porter <kyle@cmwmedia.com>
Tue 2021-05-25 3:07 PM
To: You
I will seek a response from the team and circle back with you shortly – thank you for the note and we appreciate the support!
Kyle Porter
CEO/President, CMW Media
602-402-5628"
Still waiting...
I emailed the CEO like they said to do Re: convertible notes and he responded that he would circle back once he checked with his team. He has not responded since, despite my follow ups. Disappointing...
Having said that, it's good to see CFGN back off, today and news is very positive.
Yes I'm pumped, and he's still very bullish on carbon credit offsets opportunities. That's going to be astronomical revenue IMHO!
Feb-Apr has been good to me. May has been dead! Out of 45 stocks I monitor, one is up 15% and all others are about even or slightly down. Boring Lol
Yeah, penny market summer blahs. QNTA should be going crazy on news! Oh well, things will pick up eventually. Too many catalysts!
Spoke with Watkins yesterday and he is very confident about Fins coming out soon. UNSS rocket ship is on high alert for imminent takeoff!
Investors starting to wake up Lol. Slow start but pace is picking up. QNTA should be going viral soon!
This is the best part...CFGN staying away. Strange that volume is so low on great news!
Sure is! This is a Hold for me. Could be up several pennies soon!!
CCTL GO!!